Pennsylvania Alerts Public on Rare Congenital Measles Cases Not Seen in Decades

The Pennsylvania Department of Health issued a significant health alert on Monday, highlighting a troubling rise in measles cases among pregnant individuals and a resurgence of congenital measles. Prior to this outbreak, such cases had not been recorded in decades, marking a concerning trend in public health.

The alert provided comprehensive clinical guidance on handling measles exposures during pregnancy and in newborns. Many healthcare professionals are encountering these cases for the first time, a stark contrast to years of effective vaccination against measles through the measles, mumps, and rubella (MMR) vaccine. A decline in vaccination rates nationwide has allowed the highly contagious virus to gain traction within communities, particularly in areas with lower immunization coverage.

As of October 19, the state had reported a total of 1,286 measles cases across 42 counties this year. Among these, 247 individuals have required hospitalization and six fatalities have been linked to the outbreak. Notably, the latest death is under investigation by state authorities before it contributes to the official count.

Recent reports indicate there have been 53 measles cases associated with pregnancy. Tragically, at least one case of congenital measles has led to a death; specifically, a newborn boy who died shortly after birth while his mother suffered from severe measles.

Understanding the Risks

Individuals who are pregnant and have not been vaccinated or have not previously contracted measles are at significant risk. Contracting measles during pregnancy can lead to serious complications including hospitalization, pneumonia, and even death. It heightens the risks of miscarriage, stillbirth, low birth weight, and preterm labor. Due to the nature of the MMR vaccine, which is a live attenuated vaccine, it is not recommended during pregnancy because of potential risks to a developing fetus. In cases of exposure, intravenous immunoglobulin is advised within six days to mitigate the risk of infection.